Lv1
60 积分 2025-10-21 加入
Metabolic engineering for optimized CAR-T cell therapy
1天前
已完结
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells
1天前
已完结
ENTPD1/CD39 is a promising therapeutic target in oncology
3个月前
已完结
Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine Synthesis
4个月前
已完结
皖公网安备34019202002308
